0      0


Expert Roundtable


Jun 24, 2020 12:00am ‐ Sep 11, 2020 6:08am


Credits: None available.

Description

Expert Roundtable

Expert Roundtable: How do we realize the full potential for Small Molecule in the new decade? Panel discussion with experts in the area of small molecule continuous manufacturing will discuss the technical, regulatory, and business hurdles for continuous manufacturing. This session will highlight CM as a continuum from E2E to hybrid approaches, including the need for "batch steps" for some products, requirement differences which can be a hindrance to global implementation of advanced technologies enabled by CM such as PAT, RTRT, and modeling; and why E2E CM may or may not be the optimal solution.        

  • Malcolm Berry, PhD, CEO & Founder MB
    Chemistry Consulting, Ltd.    
  • Sharmista Chatterjee, PhD, Division Director OPMA,
    OPQ/CDER  
  • Gabriella Dahlgren, PhD, Manager, Strategy Deployment
    Janssen Supply Group LLC      
  • Elizabeth Grieco, Director Vertex  
  • Michael O’Brien, PhD, Founder and President NGT
    BioPharma Consultants

Leader/Speaker(s):

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.